This inventor holds 1 USPTO granted patent. Top assignee: Chebigen Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Tae-Sung Bae: Innovator in Anti-Cancer Pharmaceutical Composition
Introduction
Tae-Sung Bae is a notable inventor based in Jeonlabuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Tae-Sung Bae holds a patent for "Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds." This invention relates to a novel retinoid derivative compound represented by a specific formula. The compound is designed to exert high anti-cancer effects while minimizing undesirable side effects. This advancement in pharmaceutical composition showcases his commitment to improving cancer therapies.
Career Highlights
Throughout his career, Tae-Sung Bae has been associated with Chebigen Co., Ltd., where he has focused on research and development in the pharmaceutical sector. His work has led to the creation of effective compounds that can potentially change the landscape of cancer treatment.
Collaborations
Tae-Sung Bae has collaborated with notable colleagues, including Hong-Sig Sin and Soo-Jong Um. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Tae-Sung Bae's contributions to the development of anti-cancer pharmaceutical compositions highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile